A new study of the type 2 diabetes drug tirzepatide found it also resulted in dramatic weight loss, offering hope for those struggling with obesity.
Author: Karen Weintraub, USA TODAY
Monkeypox cases may be mistaken for a sexual transmitted disease, CDC warns
So far, 5 Americans are likely infected with monkeypox, the CDC said Monday. Health officials are trying to determine how the cases may be connected.
Nasal vaccines may be the next generation of protection against COVID
Researchers hope a nasal delivery system will make for a COVID vaccine that is better at preventing transmission and mild infections.
Why do my dogs smell like orange slices? The latest research on how COVID messes with smell
Most people hit early with coronavirus lost their smell. Now, not so much. Scientists are starting to figure out why and what that means.
FDA authorizes second COVID booster shot for Americans 50 and older
Under the FDA’s decision, a second booster shot of the Pfizer or Moderna COVID vaccine is allowed for those 50 and up.
Pfizer-BioNTech requests FDA authorization for fourth COVID vaccine shot for 65 and older
It’s not clear how long the Food and Drug Administration will take to review the request or whether it will convene its expert panel to review it.
Just how bad is it to be in ICU with COVID? Far more miserable than people realize, experts say
Weeks of sedation, months of rehab and perhaps years of lingering symptoms is typical for people who have ended up in an ICU because of COVID.
Can Biden’s ‘Cancer Moonshot’ succeed? It’s possible, experts say, but it will take more than words
Experts are thrilled by Biden’s pledge to cut the cancer death rate in half in 25 years, but they say it will take more money and greater equity.
Omicron’s new variant cousin, BA.2, has arrived in the US. But don’t panic yet, experts say.
Cases of omicron BA.2 have been reported in at least four states – California, New Mexico, Texas and Washington – and on three other continents.
Pfizer and BioNTech announce plans to test omicron-specific COVID-19 vaccine in adult trials
Pfizer and BioNTech will conduct three simultaneous trials in adults to determine if an omicron-specific vaccine is more effective than current shots.